Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Receivables - Other (2016 - 2023)

Historic Receivables - Other for Palisade Bio (PALI) over the last 7 years, with Q4 2023 value amounting to $105625.0.

  • Palisade Bio's Receivables - Other fell 2522.12% to $105625.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $105625.0, marking a year-over-year decrease of 2522.12%. This contributed to the annual value of $105625.0 for FY2023, which is 2522.12% down from last year.
  • As of Q4 2023, Palisade Bio's Receivables - Other stood at $105625.0, which was down 2522.12% from $105625.0 recorded in Q3 2023.
  • Over the past 5 years, Palisade Bio's Receivables - Other peaked at $229000.0 during Q1 2019, and registered a low of $105625.0 during Q2 2023.
  • Its 4-year average for Receivables - Other is $187375.0, with a median of $229000.0 in 2019.
  • Per our database at Business Quant, Palisade Bio's Receivables - Other soared by 26788.33% in 2019 and then tumbled by 2522.12% in 2023.
  • Quarter analysis of 4 years shows Palisade Bio's Receivables - Other stood at $229000.0 in 2019, then changed by 0.0% to $229000.0 in 2020, then crashed by 38.32% to $141250.0 in 2022, then fell by 25.22% to $105625.0 in 2023.
  • Its last three reported values are $105625.0 in Q4 2023, $105625.0 for Q3 2023, and $105625.0 during Q2 2023.